| Dr V Krishnarao Chevuru, MD | |
|
3622 Belmont Ave, Suite1, Youngstown, OH 44505-1450 | |
| (330) 759-9350 | |
| (330) 759-9387 |
| Full Name | Dr V Krishnarao Chevuru |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 3622 Belmont Ave, Youngstown, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326033762 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 35041522K (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr V Krishnarao Chevuru, MD 3622 Belmont Ave, Suite1, Youngstown, OH 44505-1450 Ph: (330) 759-9350 | Dr V Krishnarao Chevuru, MD 3622 Belmont Ave, Suite1, Youngstown, OH 44505-1450 Ph: (330) 759-9350 |
News Archive
The Medicines Patent Pool announced a licence today with MSD, known as Merck in the United States and Canada, for paediatric formulations of raltegravir, a key medicine approved for children living with HIV four weeks of age and older.
The U.S. Food and Drug Administration today approved Lumoxiti (moxetumomab pasudotox-tdfk) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.
An innovative cardiac rehabilitation intervention started earlier and more custom-tailored to the individual improved physical function, frailty, quality-of-life, and depression in hospitalized heart failure patients, compared to traditional rehabilitation programs.
UT social work professor Sunha Choi recently published an article in Population Health Management on the effects of Medicaid expansion on low-income individuals' access to health care.
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.
› Verified 7 days ago
Dr. Charles Daniel Cammock, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-3658 Fax: 330-480-3439 | |
James A Bachmeier, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3622 Belmont Ave, Suite 1, Youngstown, OH 44505 Phone: 330-759-9350 Fax: 330-759-9387 | |
Bijo Jos Thomas, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-3658 Fax: 330-480-3439 | |
Frederick A. Peachman, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1044 Belmont Ave, Youngstown, OH 44504 Phone: 330-480-3658 Fax: 330-480-3439 | |
Yvette R Walker, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 500 Gypsy Ln, Youngstown, OH 44504 Phone: 330-884-1000 | |
Dr. Heather C Eck, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 8401 Market St, Youngstown, OH 44512 Phone: 330-729-2929 Fax: 330-286-5396 | |
Dr. Raymond George Malackany, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3622 Belmont Ave, Suite1, Youngstown, OH 44505 Phone: 330-759-9350 Fax: 330-759-9387 |